BioCentury
ARTICLE | Clinical News

Omnaris ciclesonide nasal spray regulatory update

October 30, 2006 8:00 AM UTC

FDA approved ALT's Omnaris ciclesonide nasal spray to treat nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 12 years of age and older. However, ALT said FDA determi...